Figures
Abstract
Background and purpose
The ability of the abbreviated burn severity index (ABSI) to predict death among patients with severe burns remains unclear. This meta-analysis aimed to identify the association between the ABSI and mortality in severely burned patients.
Methods
The PubMed, EMBASE and Web of Science databases were searched up to September 15, 2024. The odds ratios (ORs) with 95% confidence intervals (CIs) were combined, and a subgroup analysis was conducted on the basis of age, ABSI grouping method and OR source. All the statistical analyses were performed with STATA version 15.0.
Results
Sixteen studies with 4011 cases were included in the analysis. The pooled results demonstrated that an elevated ABSI was significantly related to an increased risk of mortality (OR = 1.72, 95% CI: 1.48–2.00; P < 0.001). In addition, subgroup analysis by age (adult: OR = 1.35, P < 0.001; child: OR = 68.40, P < 0.001), ABSI grouping method (dichotomous: OR = 16.14, P < 0.001; continuous: OR = 1.59, P < 0.001) and OR source (univariate: OR = 11.42, P = 0.015; multivariate: OR = 1.51, P < 0.001) yielded similar results.
Citation: Deng G, Tang L, Yang Q, Li Z (2025) Association of the abbreviated burn severity index with mortality in severely burned patients: A meta-analysis. PLoS ONE 20(2): e0319199. https://doi.org/10.1371/journal.pone.0319199
Editor: David M. Burmeister, Uniformed Services University of the Health Sciences, UNITED STATES OF AMERICA
Received: October 12, 2024; Accepted: January 28, 2025; Published: February 20, 2025
Copyright: © 2025 Deng et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All data used in this work have been presented in the Supplementary Data File.
Funding: This work was funded by the Key Projects of Science and Technology Department of Sichuan Province(2024YFFK0063).
Competing interests: The authors have declared that no competing interests exist.
Introduction
Burn injuries are among the most severe forms of skin damage and are among the leading causes of trauma. In recent years, their incidence has increased worldwide [1,2]. In 2019, over 8 million burn cases were reported worldwide, and more than 110,000 patients died from severe burns [3]. Typically, burns are initially assessed according to total body surface area (TBSA) affected and the depth of skin damage. First-degree burns are the most superficial thermal injuries, as they affect only the epidermis. Second-degree burns are further divided into superficial partial burns and deep partial burns, which generally involve the epidermis and dermis but not deeper structures. Full-thickness burns, described as third-degree burns, affect the entire epidermis, dermis, and underlying tissues [4,5]. Clinically, severe burns are the most challenging and often require surgical intervention.
Assessing the prognosis of patients with severe burns typically requires the consideration of multiple factors. The most commonly used indicators are the total body surface area (TBSA) burned, burn depth and age [6]. Generally, larger burn areas (greater than 30%) and deeper burns, such as deep partial-thickness and full-thickness burns (third-degree burns), are associated with worse outcomes [6]. In addition, young children and elderly individuals, due to their thinner skin and weaker immune function, tend to have poorer outcomes when experiencing burns of the same severity [7,8]. If a patient has inhalation injuries, such as those caused by the inhalation of hot smoke or chemical gases, and airway damage ensues, the prognosis worsens, which results in a higher mortality rate [9]. Additionally, underlying conditions such as diabetes, heart disease, and renal failure can impair the body’s ability to recover from burns, which leads to a poorer prognosis [10]. Severe burn patients are prone to infections, especially those with extensive burns, and infection is one of the leading causes of death in these patients [11]. Therefore, the prognosis of patients with severe burns is based on multiple factors. Some scoring tools reported in the literature, such as the Baux score (based on age and burn area) and the revised Baux score (based on age, burn area and inhalation injury), still consider relatively few factors, which limits their clinical application [12,13].
The abbreviated burn severity index (ABSI), which was introduced in 1982, is a prognostic indicator that is based on sex, age, inhalation injury, occurrence of third-degree burns and total burned area [14]. In recent decades, this tool has been investigated in several studies since 2015 and is believed to have some prognostic value in severely burned patients. However, the results of these studies varied, and the clinical value of the ABSI in predicting mortality in patients with severe burns still lacks high-level evidence. Therefore, for the first time, this meta-analysis aimed to further clarify the association between the ABSI and the risk of mortality in patients with severe burns.
Materials and methods
The meta-analysis in this study was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 [15].
Ethics Statement
The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All procedures and studies that involved human participants were performed in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
Literature search
We searched the PubMed, EMBASE and Web of Science databases from database inception up to September 15, 2024, for the following key words: abbreviated burn severity index, ABSI, burn, mortality, survival, prognosis, and death. The detailed search strategy was as follows: (abbreviated burn severity index OR ABSI) AND burn AND (mortality OR survival OR prognostic OR prognosis OR death). MeSH terms and free texts were used, and the references cited in the included studies were reviewed.
Inclusion criteria
Studies that met the following criteria were included: 1) patients included had severe burns, which are defined as those requiring transfer to a designated burn center for treatment according to established guidelines [16,17]; 2) the ABSI was evaluated according to sex (female: score 1; male: score 0), age (0–20 years: score 1; 21–40 years: score 2; 41–60 years: score 3; 61–80 years: score 4; 81–100 years: score 5), inhalation injury (with: score 1; without: score 0), third-degree burns (with: score 1; without: score 0) and total burned area (1–10%: score 1; 11–20%: score 2; 21–30%: score 3; 31–40%: score 4; 40–50%: score 5; 50–60%: score 6; 60–70%: score 7; 70–80%: score 8; 80–90%: score 9; 90–100%: score 10), with scores ranging from 2–19; and 3) the association of the ABSI values with mortality was explored.
Exclusion criteria
Studies that met the following criteria were excluded: 1) those with insufficient, duplicated or overlapping data; 2) publications that were letters, editorials, animal trials, case reports or reviews; and 3) low-quality studies with a Newcastle‒Ottawa Scale score less than 6 [18]; 4) studies without the OR and 95% CI for pooled analysis.
Data collection
We collected the following information from the included studies: the first author, publication year, country, sample size, age, ABSI grouping method (cutoff value or continuous), source of OR (univariate or multivariate analysis), NOS, OR and 95% CI. Furthermore, for missing data except for the OR and 95% CI, we presented them as “not reported (NR)”.
Methodological quality assessment
All included studies were cohort studies. Therefore, the NOS scoring tool was used to assess the quality of the included studies. Only studies with an NOS score > 5 were included [18].
Two investigators independently performed the literature search, selection, data extraction, and methodological quality assessment, and all disagreements were resolved by team discussion.
Statistical analysis
All the statistical analyses were performed via STATA (version 15.0) software. Heterogeneity between studies was assessed by I2 statistics and the Q test. When significant heterogeneity was observed (I2 > 50% and/or P < 0.1), the random-effects model was used; otherwise, the fixed-effects model was applied. ORs and 95% CIs were combined to evaluate the relationship between the ABSI and mortality. A subgroup analysis stratified by age, ABSI grouping method and OR source was then conducted. Next, a sensitivity analysis was conducted to detect the sources of heterogeneity and to assess the stability of the overall results. In addition, Begg’s funnel plot and Egger’s test were performed to detect publication bias, and significant publication bias was defined as P < 0.05 [19,20]. If obvious publication bias was observed, the trim-and-fill method was applied to clarify potentially unpublished studies [21].
Results
Literature search and selection
As presented in Fig 1, 741 publications were identified from three databases (PubMed: n = 223; EMBASE: n = 260; Web of Science: n = 258), and 130 duplicates were removed. In all, 453 and 98 records were excluded after reviewing the titles and abstracts, respectively. Eventually, after reviewing the full texts, 44 studies were further excluded (S1 Table). Therefore, 16 studies were included in the meta-analysis [22–37].
Basic characteristics of the included studies
These 16 studies were published between 2015 and 2024 and included a total of 4011 participants. Most studies focused on adult patients, while one study enrolled only children. In five of the included studies, patients were divided into different groups according to the cutoff values of the ABSI, and the ABSI was analyzed as a continuous variable in the other seven studies. In most studies, the ORs and 95% CIs were extracted from the multivariate analysis (11/16). Other data are presented in Table 1. Besides, the detailed information for the NOS score was shown in S2 Table.
Associations between the ABSI and mortality in patients with severe burns
The pooled results demonstrated that an elevated ABSI significantly increased the risk of mortality (OR = 1.72, 95% CI: 1.48–2.00, P < 0.001; I2 = 95.6%, P < 0.001) (Fig 2).
A subgroup analysis on the basis of age (adult: OR = 1.35, 95% CI: 1.20–1.51, P < 0.001; child: OR = 68.40, 95% CI: 9.11–513.81, P < 0.001), ABSI grouping method (dichotomous: OR = 16.14, 95% CI: 3.83–68.03, P < 0.001; continuous: OR = 1.59, 95% CI: 1.38–1.84, P < 0.001) and source of OR (univariate: OR = 11.42, 95% CI: 1.61–81.17, P = 0.015; multivariate: OR = 1.51, 95% CI: 1.31–1.74, P < 0.001) yielded similar results (Table 2).
Sensitivity analysis and publication bias
The sensitivity analysis revealed that our results were stable and reliable and that none of the included studies had a significant effect on the overall conclusion (Fig 3).
Begg’s funnel plot (Fig 4) and Egger’s test (P = 0.003) indicated significant bias. Therefore, the trim-and-fill method was applied, and seven potentially unpublished studies were detected (Fig 5). However, these seven studies did not affect the overall findings and had an OR of 1.48 (95% CI: 1.28–1.70, P < 0.001).
Discussion
Our meta-analysis demonstrated that the ABSI is a reliable and valuable predictive indicator of mortality in severely burned patients and that patients with higher ABSI have an increased risk of mortality. Moreover, the subgroup analysis on the basis of age, ABSI grouping method and OR source further verified the above findings. Our study provides high-level evidence for the clinical application of the ABSI in severely burned patients.
The direct causes of death in patients with severe burns primarily include infection and multiple organ failure. Severe burns lead to destruction of the skin barrier, which increases the vulnerability of patients to bacterial, viral, and fungal infections. Consequently, postburn infections, particularly sepsis, are among the main causes of mortality [38,39]. Additionally, extensive burns can trigger systemic inflammatory response syndrome (SIRS), which leads to the failure of multiple organs, such as the heart, lungs, and kidneys, ultimately resulting in death [40]. Furthermore, the inhalation of hot smoke, toxic gases, or chemicals can cause airway damage and result in acute respiratory distress syndrome (ARDS) or pneumonia, which worsens the patient’s condition and increases mortality rates [41,42]. Fluid loss and increased vascular permeability after burns can easily lead to hypovolemic shock, and if timely resuscitation and fluid replacement are not provided, it can lead to organ ischemia and death. Severe burns can also cause electrolyte and metabolic disturbances, such as hyperkalemia, hyponatremia, and acidosis, which can affect the function of the heart and other organs, posing life-threatening risks [43]. Other factors, such as acute renal failure, malnutrition, and decreased immunity, are also risk factors that can exacerbate this condition [44,45]. However, these factors often do not exist in isolation, and the death of burn patients is typically the result of multiple contributing factors. The indicators included in the ABSI, such as age, burn area, and the occurrence of third-degree burns, can effectively reflect the risk of developing the aforementioned complications, thereby predicting the risk of mortality.
The ABSI score, introduced in 1982, has been widely utilized as a prognostic tool for assessing mortality risk in burn patients [14]. However, over the past few decades, the validity of the ABSI score has been questioned because of advancements in burn care and the emergence of more sophisticated prognostic tools. One of the main criticisms is that the original score was developed based on patient data from a different era, with medical practices and outcomes that may not fully align with contemporary standards. For example, improvements in intensive care, fluid resuscitation, infection control, and surgical interventions have significantly enhanced patient survival, particularly among those with severe burns [46]. Additionally, some studies have suggested that the weight of certain variables in the ABSI score, such as sex or age, may not reflect the same level of prognostic significance in modern clinical settings [47]. Despite these criticisms, recent studies have reaffirmed the utility of the ABSI score, particularly in resource-limited settings or as a baseline comparison for newer predictive models [48]. These findings underscore the importance of continuously validating and updating prognostic tools such as the ABSI to ensure their relevance in guiding clinical decision-making and improving patient outcomes.
Among the included studies, only one focused on pediatric patients [25]. However, as we mentioned in the inclusion criteria, age is an important parameter of the ABSI, and patient age ≤ 20 years is defined as a score of 1. Therefore, the prognostic value of the ABSI in children requires further validation or adjustment. In addition, our meta-analysis focused on the ability of the ABSI to predict the risk of death in patients with severe burns. The associations of ABSI with other postburn complications, such as infection, acute renal failure, arrhythmia and cicatrization, should also be explored, but relevant studies are still limited. In most of the included studies, the ABSI was treated as a continuous variable, whereas in some studies, it was categorized as a binary variable. Although we performed a subgroup analysis to address this issue, for better clinical application of the ABSI in patient risk assessment, more precise risk stratification may still be needed.
This meta-analysis has several limitations. First, the overall sample size was relatively small, and most included studies were retrospective, which might cause some bias. Second, the heterogeneity discovered during the meta-analysis was high, and identifying the source of high heterogeneity was difficult. Third, we were unable to conduct more subgroup analyses based on other important parameters, such as the type of burn and cutoff value of the ABSI, due to the lack of original data. Fourth, we did not compare the prognostic value of the ABSI with that of other similar indicators, such as the Baux score, which is also difficult to achieve in meta-analyses because of the lack of original data.
Conclusion
The ABSI serves as a reliable prognostic indicator in patients with severe burns. Unlike previous studies, this meta-analysis provides robust evidence for the clinical utility of the ABSI. Our findings reinforce that patients with elevated ABSI scores are at an increased risk of mortality, which emphasizes the importance of this indicator in risk stratification and in guiding treatment prioritization in modern burn care. However, due to the limitations of our meta-analysis and in the included studies, more high-quality studies are still needed to verify our findings.
Suppporting information
S1 Table. Reasons for inclusion or exclusion of all publications.
https://doi.org/10.1371/journal.pone.0319199.s001
(XLSX)
S1 File. All relevant data used in this work.
https://doi.org/10.1371/journal.pone.0319199.s003
(XLSX)
References
- 1. Alqirnas MQ, Jarman YA, Almosa AS, Alharbi SS, Alhamadh MS, Qasim SS, et al. Predictors of sepsis and sepsis-related mortality in critically ill burn patients: a single tertiary care center experience. Plast Reconstr Surg Glob Open. 2024;12(9):e6180. pmid:39296606
- 2. Stanton EW, Manasyan A, Thompson CM, Patel GP, Lacey AM, Travis TE, et al. Venous thromboembolism incidence, risk factors, and prophylaxis in burn patients: a national trauma database study. J Burn Care Res. 2024.
- 3. Yakupu A, Zhang J, Dong W, Song F, Dong J, Lu S. The epidemiological characteristic and trends of burns globally. BMC Public Health. 2022;22(1):1596. pmid:35996116
- 4. Jiang Y, Wang ZF, Wang B, Hu L, Zhu B, Wu G, et al. Epidemiological characteristics and outcome analysis of inhalation injury patients combined with burn area less than 30% total body surface area in a single center from 2008 to 2016. Zhonghua Shao Shang Za Zhi. 2021;37:1–10. pmid:33874705
- 5. Patterson KN, Onwuka A, Schwartz DM, Fabia RB, Thakkar RK. Length of stay per total body surface area burn: a validation study using the national burn registry. J Burn Care Res. 2022;43(6):1227–32. pmid:35986486
- 6. Ho HL, Halim AS, Sulaiman WAW, Fatimah MJ. Estimation of total body surface area burned: a comparison between burn unit and referring facilities. Ann Burns Fire Disasters. 2023;36(1):19–28pmid:38680901
- 7. Zhang JP, Huang YS. Current situation and reflection on the prevention and treatment of burns in the elderly. Zhonghua Shao Shang Za Zhi. 2017;33(9):529–32. pmid:28926872
- 8. Expert consensus on the management of deep partial-thickness burn wounds in pediatric patients (2023 version). Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023;39(10):901–10.
- 9. Cox RA, Burke AS, Soejima K, Murakami K, Katahira J, Traber LD, et al. Airway obstruction in sheep with burn and smoke inhalation injuries. Am J Respir Cell Mol Biol. 2003;29(3 Pt 1):295–302. pmid:12936906
- 10. Resch A, Neumueller A, Christ A, Staud C, Hacker S. Chronic kidney disease and cardiovascular disease reduce survival rates after burn injury: a retrospective study over 20 years. Surgery. 2024;175(4):1198–204. pmid:38135554
- 11. Yao YM, Luan YY. New understanding on the immunity for severe infections and complications in burns and trauma. Zhonghua Shao Shang Za Zhi. 2021;37(6):519–23. pmid:34139832
- 12. Saadat GH, Toor R, Mazhar F, Bajani F, Tatebe L, Schlanser V, et al. Severe burn injury: body mass index and the baux score. Burns. 2021;47(1):72–7. pmid:33234365
- 13. Edgar MC, Bond SM, Jiang SH, Scharf IM, Bejarano G, Vrouwe SQ. The revised baux score as a predictor of burn mortality: a systematic review and meta-analysis. J Burn Care Res. 2023;44(6):1278–88. pmid:37220881
- 14. Tobiasen J, Hiebert JM, Edlich RF. The abbreviated burn severity index. Ann Emerg Med. 1982;11(5):260–2. pmid:7073049
- 15. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71. pmid:33782057
- 16. Luo G, Yuan Z, Peng Y, Huang Y, Wu J; Chinese Burn Association. Chinese burn referral criteria (2018 version). Zhonghua Shao Shang Za Zhi. 2018;34(11):759–60. pmid:30481913
- 17. American Burn Association. Guidelines for Burn Patient Referral. Available from: https://ameriburn.org/resources/burnreferral/?utm_source.
- 18. Wang Y, Li J, Chang S, Dong Y, Che G. Risk and influencing factors for subsequent primary lung cancer after treatment of breast cancer: a systematic review and two meta-analyses based on four million cases. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer. 2021;16(11):1893–908. pmid:34256110
- 19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101pmid:7786990
- 20. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research ed). 1997;315(7109):629–34. pmid:9310563
- 21. Shi L, Lin L. The trim-and-fill method for publication bias: practical guidelines and recommendations based on a large database of meta-analyses. Medicine (Baltim). 2019;98(23):e15987. pmid:31169736
- 22. Heng JS, Clancy O, Atkins J, Leon-Villapalos J, Williams AJ, Keays R, et al. Revised baux score and updated Charlson comorbidity index are independently associated with mortality in burns intensive care patients. Burns. 2015;41(7):1420–7. pmid:26187055
- 23. Pantet O, Faouzi M, Brusselaers N, Vernay A, Berger MM. Comparison of mortality prediction models and validation of SAPS II in critically ill burns patients. Ann Burns Fire Disasters. 2016;29(2):123–9pmid:28149234
- 24. Yoon J, Kim Y, Yim H, Cho YS, Kym D, Hur J, et al. Analysis of prognostic factors for acute kidney injury with continuous renal replacement therapy in severely burned patients. Burns. 2017;43(7):1418–26. pmid:28420565
- 25. Barcellos LG, Silva A, Piva JP, Rech L, Brondani TG. Characteristics and outcome of burned children admitted to a pediatric intensive care unit. Rev Bras Ter Intensiva. 2018;30(3):333–7.
- 26. Shahi HR, Vahedian M, Movahedi M, Bahaadinbeigy K, Hashemian M, Mirafzal A. Measuring serum albumin levels at 0 and 24h: effect on the accuracy of clinical evaluations in the prediction of burn-related mortality. Burns. 2018;44(3):709–17.
- 27. Ding XB, Chen J, Yang YT, Peng X, Yan H, Peng YZ. Retrospective cohort study on the correlation between high value of lactic acid and risk of death in 127 patients with extensive burn during shock stage. Chin J Burns. 2019;35(5):326–32. pmid:31154729
- 28. Chen B, Zhao J, Zhang Z, Li G, Jiang H, Huang Y, et al. Clinical characteristics and risk factors for severe burns complicated by early acute kidney injury. Burns. 2020;46(5):1100–6. pmid:31839503
- 29. Depret F, Amzallag J, Pollina A, Fayolle-Pivot L, Coutrot M, Chaussard M, et al; PRONOBURN group. Circulating dipeptidyl peptidase-3 at admission is associated with circulatory failure, acute kidney injury and death in severely ill burn patients. Critical Care. 2020;24(1):168. pmid:32321571
- 30. Zeng QL, Wang QM, Tao LJ, Hao F, Luo QZ. Establishment of nomogram predicting model for the death risk of extremely severe burn patients and the predictive value. Chin J Burns. 2020;36(9):845–52. pmid:32972070
- 31. Lin JC, Xu ZR, Chen ZH, Chen XD. Low-soluble TREM-like transcript-1 levels early after severe burn reflect increased coagulation disorders and predict 30-day mortality. Burns. 2021;47(6):1322–32. pmid:33958244
- 32. Lin JC, Wu GH, Zheng JJ, Chen ZH, Chen XD. Prognostic values of platelet distribution width and platelet distribution width-to-platelet ratio in severe burns. Shock. 2022;57(4):494–500. pmid:34812187
- 33. Tsolakidis S, Freytag DL, Dovern E, Alharbi Z, Kim BS, Houschyar KS, et al. Infections in burn patients: a retrospective view over seven years. Medicina. 2022;58(8):1066. pmid:36013534
- 34. Jiang M, Qian H, Li Q, Han Y, Hu K. Predictive value of lactate dehydrogenase combined with the abbreviated burn severity index for acute kidney injury and mortality in severe burn patients. Burns. 2023;49(6):1344–55. pmid:36805837
- 35. Niculae A, Peride I, Tiglis M, Nechita AM, Petcu LC, Neagu TP. Emergency care for burn patients-a single-center report. J Personal Med. 2023;13(2):238. pmid:36836472
- 36. Nitescu B, Pavel B, Tache IA, Pop IA, Balan CI, Arama SS, et al. Predictive values of presepsin and C-reactive protein on prognosis in severe burns. Farmacia. 2023;71(3):511–7.
- 37. Christ A, Staud CJ, Krotka P, Resch A, Neumueller A, Radtke C. revalidating the prognostic relevance of the abbreviated burn severity index (ABSI): a twenty-year experience examining the performance of the ABSI score in consideration of progression and advantages of burn treatments from a single center in Vienna. J Plast Reconstr Aesthet Surg. 2024;94:160–8.
- 38. Gu F, He W, Zhu D, Yang P, Sun J, Han L. A 10-year retrospective study of methicillin-resistant Staphylococcus aureus from burn wound infection in southeast China from 2013 to 2022. Front Microbiol. 2023;14:1301744. pmid:38107851
- 39. Veronica RM, Nelwan EJ, Kumalawati J, Rumende CM, Chen K, Simadibrata M, et al. The effect of multidrug-resistant organism infection on mortality of burn patients at RSUPN Dr. Cipto Mangunkusumo. Ann Burns Fire Disasters. 2024;37(2):159–68pmid:38974796
- 40. Gibson BHY, Wollenman CC, Moore-Lotridge SN, Keller PR, Summitt JB, Revenko AR, et al. Plasmin drives burn-induced systemic inflammatory response syndrome. JCI Insight. 2021;6(23):e154439. pmid:34877937
- 41. Bittner E, Sheridan R. Acute respiratory distress syndrome, mechanical ventilation, and inhalation injury in burn patients. Surg Clin North Am. 2023;103(3):439–51. pmid:37149380
- 42. Akın M, Tuncer HB, Akgün AE, Erkılıç E. New treatment modality for burn injury-related acute respiratory distress syndrome: high-flow nasal oxygen therapy in major burns. J Burn Care Res. 2024;45(4):1060–5. pmid:38630547
- 43. Ackerman BH, Patton ML, Guilday RE, Haith LR, Jr, Stair-Buchmann M, Reigart CL. Trimethoprim-induced hyperkalemia in burn patients treated with intravenous or oral trimethoprim sulfamethoxazole for methicillin-resistant Staphylococcus aureus and other infections: nature or nurture? J Burn Care Res. 2013;34(1):127–32. pmid:23292580
- 44. Mustonen KM, Vuola J. Acute renal failure in intensive care burn patients (ARF in burn patients). J Burn Care Res. 2008;29(1):227–37. pmid:18182927
- 45. Ashrafi-Asgarabad A, Safiri S. Pre-burn malnutrition increases operative mortality in burn patients who undergo early excision and grafting in a sub-Saharan African burn unit: methodological issues. Burns. 2018;44(6):1615. pmid:29884530
- 46. Snell JA, Loh NH, Mahambrey T, Shokrollahi K. Clinical review: the critical care management of the burn patient. Crit Care. 2013;17(5):241. pmid:24093225
- 47. Christ A, Staud CJ, Krotka P, Resch A, Neumüller A, Radtke C. Revalidating the prognostic relevance of the abbreviated burn severity index (ABSI): a twenty-year experience examining the performance of the ABSI score in consideration of progression and advantages of burn treatments from a single center in Vienna. J Plast Reconstr Aesthet Surg. 2024;94:160–8. pmid:38805847
- 48. Herlianita R, Purwanto E, Wahyuningsih I, Pratiwi ID. Clinical outcome and comparison of burn injury scoring systems in burn patient in Indonesia. Afr J Emerg Med. 2021;11(3):331–4. pmid:34141527